|
Neonatal Withdrawal Inventory
Guidelines to Test for Perinatal Substance Exposure
Goal:The following guidelines should help to make the process of drug
testing of neonates unbiased. This should also lead to more consistent
identification and effective care of the infants who screen positive.
Click here to view the Neonatal
Withdrawl Inventory Flow Sheet.
Consider newborn drug screen if any of these risks are present
Evaluation
Drug screening specimen from infant should be obtained
as soon as suspicion arises. At that time, the parents will need to be
notified that drug screening has been ordered.
-
Step 1: < 48 hours of age: urine drug screen and save
all meconium
-
Step 2: If urine drug screen is negative
but suspicion remains, send all meconium for drug screen
-
Step 3: If meconium has been passed and the
suspicion of drug abuse arises, send hair screen (send 50mg)
Consideration:
-
All drug specimens should be stored in blue
tops (non-sterile) or urine cups and need to be sealed i.e. with patient
label and initialed by RN at the bedside.
-
Keep specimen refrigerated, wrap specimen in
aluminum foil to shelter from light, if LSD use is suspected. Each
patient will have a specimen bag or container in the specimen
refrigerator.
-
Nurse will notify MD when all meconium is
passed and collection complete and can be sent to the laboratory.
-
Case managers will follow up on drug screen
results if infant has been discharged.
-
Urine drug screen: limited in detection of THC
however least expensive and most rapid screen.
-
Meconium drug screen:
-
can
detect usage back to 20 weeks gestation.
-
less dependable in ELBW
-
1st
meconium often negative, 2nd or 3rd passage have
higher yield
-
limited use of meconium-stained amniotic fluid or transitional stools,
best to send all meconium stools
-
Meconium
ETOH screen still limited due to false positive O
-
Hair drug screen
-
limited in extremely premature infants secondary to little or no hair
-
THC
difficult to detect, requires excessive abuse of THC
|